Stock events for AquaBounty Technologies, Inc. (AQB)
AquaBounty Technologies, Inc.'s stock price declined approximately 46.36% over the past six months. Key events include the announcement of third-quarter and full-year 2025 financial results, Nasdaq listing concerns due to low market value, an increase in short interest, a reduced net loss for 2025, uncertainty about the company's ability to continue as a going concern, and additional impairment charges on the Ohio Farm Project.
Demand Seasonality affecting AquaBounty Technologies, Inc.’s stock price
There is no direct information available regarding the demand seasonality for AquaBounty's specific products and services. Given that the company ceased fish production in 2024 and is liquidating assets, product demand seasonality is likely less relevant to its current operational focus. Information on seasonality pertains to the historical seasonal performance of its stock price.
Overview of AquaBounty Technologies, Inc.’s business
AquaBounty Technologies, Inc. is a biotechnology and aquaculture company focused on enhancing productivity and sustainability in the aquaculture industry through genetically modified fish. Their primary product was the AquAdvantage Salmon, which grows faster than conventional salmon. The company sold its operating farms and ceased fish production in 2024, with the Ohio Farm Project now classified as held for sale. The company aimed to meet consumer demand for high-quality seafood while addressing production constraints.
AQB’s Geographic footprint
AquaBounty Technologies, Inc. is headquartered in Harvard, Massachusetts. Historically, they operated facilities in Prince Edward Island, Canada, and Indiana, USA, but these were sold in 2024 and 2025. A planned large-scale production facility in Pioneer, Ohio, was paused due to increased costs and is now held for sale.
AQB Corporate Image Assessment
Information detailing events affecting AquaBounty Technologies, Inc.'s brand reputation in the past year is not readily available. The company's focus on genetically modified fish involves public perception and regulatory scrutiny, but no specific reputation-altering events were highlighted. The available information primarily concerns financial performance, operational changes, and stock market compliance.
Ownership
AquaBounty Technologies, Inc. has a mix of institutional and insider ownership. Institutional investors own 13.16% of the stock, while insiders hold a significant portion. Major institutional owners include Renaissance Technologies Llc, Epiq Partners, Llc, and BlackRock, Inc. The largest individual shareholder is Randal J. Kirk.
Ask Our Expert AI Analyst
Price Chart
$0.93